Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$48.52 - $58.02 $283,599 - $339,126
-5,845 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $310,194 - $357,129
5,845 New
5,845 $618,000
Q2 2020

Aug 10, 2020

SELL
$43.1 - $55.31 $238,774 - $306,417
-5,540 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$37.79 - $51.33 $209,356 - $284,368
5,540 New
5,540 $485,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $209B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Almanack Investment Partners, Llc. Portfolio

Follow Almanack Investment Partners, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.